Acute myeloblastic leukemia achieving complete remission with Amifostine alone

Ozturk A., Orhan B., Turken O., Etiz D., Yaylaci M., Uskent N.

LEUKEMIA & LYMPHOMA, cilt.43, sa.2, ss.451-453, 2002 (SCI-Expanded) identifier identifier identifier

  • Yayın Türü: Makale / Tam Makale
  • Cilt numarası: 43 Sayı: 2
  • Basım Tarihi: 2002
  • Doi Numarası: 10.1080/10428190290006341
  • Dergi Adı: LEUKEMIA & LYMPHOMA
  • Derginin Tarandığı İndeksler: Science Citation Index Expanded (SCI-EXPANDED), Scopus
  • Sayfa Sayıları: ss.451-453
  • Eskişehir Osmangazi Üniversitesi Adresli: Evet

Özet

Amifostine, a phosphorylated thiol-amine, is known as a cytoprotective agent especially for cisplatin containing chemotherapies. Apart from the cytoprotective role, Amifostine could also be used in the treatment of hematologic malignancies such as myelodysplastic syndrome (MDS) and acute myeloblastic leukemia (AML), as a treatment option or for potentiating the effects of cytotoxic agents.